Evidence map›Paper›PMID 27922111›Full record

ArticleScientific reports2016

miR-365 targets β-arrestin 2 to reverse morphine tolerance in rats.

Jian Wang, Wei Xu, Tao Zhong, Zongbin Song, Yu Zou, Zhuofeng Ding, Qulian Guo, Xinzhong Dong, Wangyuan Zou

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Jian WangDepartment of Anesthesiology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
Wei XuDepartment of Anesthesiology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
Tao ZhongDepartment of Anesthesiology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
Zongbin SongDepartment of Anesthesiology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
Yu ZouDepartment of Anesthesiology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
Zhuofeng DingDepartment of Anesthesiology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
Qulian GuoDepartment of Anesthesiology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
Xinzhong DongThe Solomon H. Snyder Department of Neuroscience, Johns Hopkins University, School of Medicine, Baltimore, Maryland 21205, USA.
Wangyuan ZouDepartment of Anesthesiology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
Xiangya Hospital Central South University · CNCentral South University · CNJohns Hopkins University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Morphine tolerance is a challenging clinical problem that limits its clinical application in pain treatment. Non-coding microRNAs (miRNAs) modulate gene expression in a post transcriptional manner, and their dysregulation causes various diseases. However, the significance of miRNAs in morphine tolerance is still poorly understood. In the present study, we hypothesized that microRNA-365 (miR-365) is a key functional small RNA that reverses morphine tolerance through regulation of β-arrestin 2 in rats. Here, microarray analysis and quantitative real-time PCR showed that miR-365 was robustly decreased in the spinal cord after chronic morphine administration. In situ hybridization and immunochemistry double staining showed that miR-365 was expressed in neurons of the spinal cord. We identified β-arrestin 2 as the target gene of miR-365 by bioinformatics analysis and luciferase reporter assay. The data showed that overexpression of miR-365 prevented and reversed established morphine tolerance, and increased expression of miR-365 caused a decrease in expression of β-arrestin 2 protein. miR-365 downregulation is involved in the development and maintenance of morphine tolerance through regulation of β-arrestin 2, and miR-365 upregulation provides a promising and novel approach for treatment of morphine tolerance.

Indexed as

Analgesics, OpioidAnimalsBase Sequencebeta-Arrestin 2Binding SitesCatheters, IndwellingDrug Administration ScheduleDrug ToleranceGene Expression RegulationGenetic VectorsInjections, SpinalLentivirusMaleMicroarray AnalysisMicroRNAsMorphineAnalgesics, OpioidArrb2 protein, ratbeta-Arrestin 2MicroRNAsMIRN365 microRNA, ratMorphine

Identifiers

PMID27922111
PMCPMC5138852
OpenAlexW2560569452

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.